Last synced on 30 November 2024 at 11:09 am

Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System

Page Type
Product Code
Definition
A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens qualitative, semi-quantitative or quantitative multiplex nucleic acid detection system is an in vitro diagnostic test for the detection, identification, and quantification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.
Physical State
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens semi-quantitative or quantitative multiplex nucleic acid detection systems are in vitro diagnostic devices that consist of reagents and associated instrumentation for detection, identification, and quantification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Technical Method
A qualitative, semi-quantitative or quantitative in vitro diagnostic assay that detects and identifies MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Target Area
Human clinical samples
Regulation Medical Specialty
Pathology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.4001
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QDS is linked to regulation 21CFR866.4001, which does not seem to exist yet. It may be pending at the moment.

Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System

Page Type
Product Code
Definition
A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens qualitative, semi-quantitative or quantitative multiplex nucleic acid detection system is an in vitro diagnostic test for the detection, identification, and quantification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.
Physical State
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens semi-quantitative or quantitative multiplex nucleic acid detection systems are in vitro diagnostic devices that consist of reagents and associated instrumentation for detection, identification, and quantification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Technical Method
A qualitative, semi-quantitative or quantitative in vitro diagnostic assay that detects and identifies MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Target Area
Human clinical samples
Regulation Medical Specialty
Pathology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.4001
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code QDS is linked to regulation 21CFR866.4001, which does not seem to exist yet. It may be pending at the moment.